⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Cognition in Breast Cancer Patients: The Impact of Cancer-related Stress

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Cognition in Breast Cancer Patients: The Impact of Cancer-related Stress

Official Title: Cognition in Breast Cancer Patients: The Impact of Cancer-related Stress

Study ID: NCT01264562

Conditions

Breast Cancer

Interventions

Study Description

Brief Summary: The study will investigate the impact of cancer-related stress and its consequences (acute and posttraumatic stress symptoms, altered cortisol secretion) on cognitive function in breast cancer patients. The hypothesis that stress associated with the cancer diagnosis and the cancer treatment is a major cause of cognitive dysfunction in breast cancer patients shall be evaluated.

Detailed Description: Primary hypothesis: \*The adverse effects of cancer and cancer therapy on cognitive function in breast cancer patients are entirely or partly mediated by stress and the ensuing dysfunction of the HPA-axis. Secondary objectives: * Determining the effect of cancer diagnosis, chemotherapy, disease-related stress, acute stress response, posttraumatic stress disorder, posttraumatic stress symptoms, anxiety, and depression on the HPA-axis in breast cancer patients * Determining the effect of cognitive dysfunction assessed with neuropsychological tests, cancer diagnosis, chemotherapy, disease-related stress, acute stress response, posttraumatic stress disorder, posttraumatic stress symptoms, anxiety, and depression on subjective cognitive function in breast cancer patients * Prevalence of acute stress response, posttraumatic stress disorder and posttraumatic stress symptoms, and extent of cancer-specific stress in breast cancer patients treated with or without chemotherapy

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Frauenklinik des Helios Amper Klinikums Dachau, Dachau, Bavaria, Germany

Kreisklinik Ebersberg, Ebersberg, Bavaria, Germany

Klinikum Landshut, Department of Obstetrics and Gynecology and Breast Cancer Services, Landshut, Bavaria, Germany

Rotkreuzklinikum Muenchen, Munich, Bavaria, Germany

Klinikum Dritter Orden, Munich, Bavaria, Germany

Ludwig Maximilian University, Department of Gynecology and Obstetrics, Munich, Bavaria, Germany

Contact Details

Name: Kerstin Hermelink, PhD

Affiliation: Ludwig Maximilian University, Department of Gynecology and Obstetrics

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: